| Original language | English |
|---|---|
| Pages (from-to) | 1263-1279 |
| Journal | Current Medical Research and Opinion |
| Volume | 28 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - Aug 2012 |
Keywords
- Advanced or metastatic breast cancer
- Aromatase inhibitor
- First line treatment
- HR
- HER2+
- Lapatinib
Cite this
}
Systematic review of lapatinib in combination with letrozole compared with other first-line treatments for hormone receptor positive(HR+) and HER2+advanced or metastatic breast cancer(MBC). / Riemsma, Rob; Forbes, Carol A.; Amonkar, Mayur M.; Lykopoulos, Konstantinos; Diaz, Jose R.; Kleijnen, Jos; Rea, Daniel W.
In: Current Medical Research and Opinion, Vol. 28, No. 8, 08.2012, p. 1263-1279.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Systematic review of lapatinib in combination with letrozole compared with other first-line treatments for hormone receptor positive(HR+) and HER2+advanced or metastatic breast cancer(MBC)
AU - Riemsma, Rob
AU - Forbes, Carol A.
AU - Amonkar, Mayur M.
AU - Lykopoulos, Konstantinos
AU - Diaz, Jose R.
AU - Kleijnen, Jos
AU - Rea, Daniel W.
PY - 2012/8
Y1 - 2012/8
KW - Advanced or metastatic breast cancer
KW - Aromatase inhibitor
KW - First line treatment
KW - HR
KW - HER2+
KW - Lapatinib
U2 - 10.1185/03007995.2012.707643
DO - 10.1185/03007995.2012.707643
M3 - Article
VL - 28
SP - 1263
EP - 1279
JO - Current Medical Research and Opinion
JF - Current Medical Research and Opinion
SN - 0300-7995
IS - 8
ER -